Mesa Laboratories, Inc.Mesa Laboratories, Inc.Mesa Laboratories, Inc.

Mesa Laboratories, Inc.

No trades
See on Supercharts
Market capitalization
‪563.41 M‬USD
‪930.00 K‬USD
‪219.08 M‬USD
‪5.21 M‬
Beta (1Y)
0.63

About Mesa Laboratories, Inc.

CEO
Gary M. Owens
Headquarters
Lakewood
Employees (FY)
698
Founded
1982
ISIN
US59064R1095
FIGI
BBG000BP3PW7
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MLAB is 105.00 USD — it has increased by 0.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mesa Laboratories, Inc. stocks are traded under the ticker MLAB.
Mesa Laboratories, Inc. is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Mesa Laboratories, Inc. has a max estimate of 130.00 USD and a min estimate of 130.00 USD.
MLAB earnings for the last quarter are 1.91 USD whereas the estimation was 1.79 USD which accounts for 6.90% surprise. Estimated earnings for the next quarter are 1.79 USD. See more details about Mesa Laboratories, Inc. earnings.
Mesa Laboratories, Inc. revenue for the last quarter amounts to ‪53.17 M‬ USD despite the estimated figure of ‪55.43 M‬ USD. In the next quarter revenue is expected to reach ‪54.90 M‬ USD.
Yes, you can track Mesa Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, MLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mesa Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MLAB reached its all-time high on Dec 28, 2021 with the price of 333.42 USD, and its all-time low was 0.25 USD and was reached on Oct 7, 1987.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 698.00 employees. See our rating of the largest employees — is Mesa Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mesa Laboratories, Inc. EBITDA is ‪34.83 M‬ USD, and current EBITDA margin is 16.64%. See more stats in Mesa Laboratories, Inc. financial statements.